Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
EOC317
i
Other names:
ACTB1003, MMKI, ACTB-1003, EDP 317, EDP317, EOC 317, EOC-317, EOC317
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
ACT Biotech, EddingPharm
Drug class:
FGFR inhibitor
Related drugs:
‹
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login